Although ALK gene fusions are known to trigger both the humoral and CTL responses in ALCL patients, there are recent reports showing that ALK fusions can also induce the expressions of an important immune checkpoint protein, programmed cell death 1 (PD-L1). The gene discussed is CD274; the disease is anaplastic large cell lymphoma.